注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Enochian Biosciences Inc是一家臨床前階段的生物科學公司。該公司利用其細胞、基因和免疫治療技術治療人類免疫缺陷病毒(HIV)、乙型肝炎病毒(HBV)、流感和冠狀病毒感染,並緩解一些非常致命的癌症。該公司的平台包括劫持RNA和同種異體細胞療法。劫持RNA平台有一種輸送機制,可適用於氣溶膠(呼吸道感染,如導致新冠肺炎和流感的病毒)和靜脈內或其他輸送機制(用於乙型肝炎病毒和HIV)。同種異體細胞治療平台具有人體免疫系統,旨在識別自我並消滅他者或非我,如細菌、病毒和癌細胞。該公司的候選產品包括ENOB-HV-01,它採用細胞和免疫療法,可以提供預防和治療HIV的疫苗。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
W. David Hardy | - | 2018 | Chairman of HIV Scientific Advisory Board |
James R. Sapirstein | 62 | 2018 | Independent Director |
Mark R. Dybul | 60 | 2018 | CEO, Director & Member of HBV Scientific Advisory Board |
Gregg Huber Alton | 57 | 2019 | Lead Independent Board Member |
Jayne McNicol | 56 | 2021 | Independent Director |
Carol L. Brosgart | 71 | 2019 | Chairperson of HBV Cure Scientific Advisory Board & Independent Director |
Rene Sindlev | 61 | 2017 | Chairman of the Board |
Steven G. Deeks | - | 2018 | Member of HIV Scientific Advisory Board |
Fabien Zoulim | - | 2020 | Member of HBV Scientific Advisory Board |
Anna Suk-fong Lok | - | 2021 | Member of HBV Scientific Advisory Board |
Richard James Whitley | 78 | 2021 | Member of Respiratory Diseases Scientific Advisory Board |
Peter Revill | - | 2020 | Member of HBV Scientific Advisory Board |
Rudolphus Gabriel Cornelis Hendriks | 77 | 2023 | Independent Director |
Avram C. Miller | 79 | 2023 | Director |
Karen Brink | - | 2024 | Director |
Leni Maria Teuntje Boerner | 61 | 2023 | Independent Director |
Geert Kazemier | - | 2024 | Chairman of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核